Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450992 · ClinicalTrials.gov registry record
TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 29
- Enrollment target
NCT04450992 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 29 participants.
The verdict
NCT04450992 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
TRACK-MSA is an observational, non-interventional, longitudinal natural history study to define changes in clinical, neurological, blood, CSF, and neuroimaging biomarkers in patients with multiple system atrophy (MSA) comparing baseline to 6-month and 1-year assessments. The study will enroll 50 patients with MSA-P or MSA-C at 2 or more participating sites.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2020-06-17 |
| Est. Completion | 2024-06-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450992
The ClinicalTrials.gov registry entry for NCT04450992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04450992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04450992 about?
NCT04450992 is a clinical study titled "TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy". TRACK-MSA is an observational, non-interventional, longitudinal natural history study to define changes in clinical, neurological, blood, CSF, and neuroimaging biomarkers in patients with multiple system atrophy (MSA) comparing baseline to 6-month and 1-year assessments. The study will enroll 50 pat...
What is the current status of trial NCT04450992?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2020-06-17. Estimated completion is 2024-06-19.
Who is sponsoring clinical trial NCT04450992?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.